Table 2.
GEM-E | GEM | p-valuea | |
---|---|---|---|
(n = 1,331) | (n = 2,936) | ||
Overall survival time, months | |||
Mean ± SD | 10.48 | 9.86 | 0.0977 |
(325.5 days ± 8.9) | (305.6 days ± 5.4) | ||
Median | 6.77 | 6.68 | |
(210 days) | (207 days) | ||
Overall survival rate per treatment time, % | |||
6 months | 56.5 | 54.7 | 0.2108 |
12 months | 27.0 | 27.3 | 0.5988 |
24 months | 12.9 | 10.6 | 0.1350 |
36 months | 9.3 | 6.5 | 0.0977 |
Abbreviation: GEM Gemcitabine, GEM-E Gemcitabine + Erlotinib
alog-rank test